Novartis To Market Newly Approved Procleix Tigris System In U.S.

Novartis To Market Newly Approved Procleix Tigris System In U.S. As The First Fully Automated System For West Nile Virus Blood Screening: "Novartis announced today that the U.S. Food and Drug Administration (FDA) has cleared the Procleix Tigris System, the first fully automated nucleic acid testing system, to screen donated blood, organs and tissue for the West Nile virus."